The recent spate of cancer drugs securing FDA approval indicates that research and development in the area are progressing rapidly. So, it is natural that every pharmaceuticals company strives to get a share of that lucrative market. The decision by GlaxoSmithKline (GSK) this week to acquire an American cancer drug maker with a promising future is … Continue reading GSK reorganization gains steam with Tesaro buyout, sale of Asia unit